232 related articles for article (PubMed ID: 29329382)
1. Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility.
Aguilar DD; Giuffrida A; Lodge DJ
Int J Neuropsychopharmacol; 2018 Apr; 21(4):393-403. PubMed ID: 29329382
[TBL] [Abstract][Full Text] [Related]
2. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
3. Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.
Aguilar DD; Chen L; Lodge DJ
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539511
[TBL] [Abstract][Full Text] [Related]
4. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
Lodge DJ; Grace AA
Int J Neuropsychopharmacol; 2012 Feb; 15(1):69-76. PubMed ID: 21329556
[TBL] [Abstract][Full Text] [Related]
5. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
Aguilar DD; Giuffrida A; Lodge DJ
J Psychopharmacol; 2016 Feb; 30(2):169-81. PubMed ID: 26510449
[TBL] [Abstract][Full Text] [Related]
6. Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat.
Perez SM; Donegan JJ; Boley AM; Aguilar DD; Giuffrida A; Lodge DJ
Schizophr Res; 2019 Apr; 206():263-270. PubMed ID: 30522798
[TBL] [Abstract][Full Text] [Related]
7. Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam.
Du Y; Grace AA
Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27432008
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.
Renard J; Loureiro M; Rosen LG; Zunder J; de Oliveira C; Schmid S; Rushlow WJ; Laviolette SR
J Neurosci; 2016 May; 36(18):5160-9. PubMed ID: 27147666
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.
Gleason KA; Birnbaum SG; Shukla A; Ghose S
Transl Psychiatry; 2012 Nov; 2(11):e199. PubMed ID: 23188199
[TBL] [Abstract][Full Text] [Related]
10. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
Gill KM; Miller SA; Grace AA
Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
[TBL] [Abstract][Full Text] [Related]
11. Human Laboratory Studies on Cannabinoids and Psychosis.
Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
[TBL] [Abstract][Full Text] [Related]
12. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
Boley AM; Perez SM; Lodge DJ
Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
[TBL] [Abstract][Full Text] [Related]
13. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids and psychosis.
D'Souza DC
Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia.
Perez SM; Lodge DJ
Mol Psychiatry; 2013 Nov; 18(11):1193-8. PubMed ID: 23979606
[TBL] [Abstract][Full Text] [Related]
16. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
Chen L; Perez SM; Lodge DJ
Dev Neurobiol; 2014 Sep; 74(9):907-17. PubMed ID: 24554310
[TBL] [Abstract][Full Text] [Related]
17. A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia.
Shah A; Lodge DJ
Transl Psychiatry; 2013 Jan; 3(1):e215. PubMed ID: 23321812
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia.
Perez SM; Aguilar DD; Neary JL; Carless MA; Giuffrida A; Lodge DJ
Neuropsychopharmacology; 2016 Jan; 41(2):477-86. PubMed ID: 26068729
[TBL] [Abstract][Full Text] [Related]
19. Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility.
Perez SM; Lodge DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109701. PubMed ID: 31299274
[TBL] [Abstract][Full Text] [Related]
20. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
Cohen M; Solowij N; Carr V
Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
